Daniel Bateman on Reminiscence Therapy

“It really focuses on maintaining the dignity of people with dementia,” Dr. Bateman tells U.S. News and World Report

Regenstrief researcher Daniel Bateman, M.D., is intrigued by reminiscence therapy and its possibilities.

Dr. Bateman spoke to U.S. News and World Report about reminiscence therapy programs like the one at Glenner Town Square in California. Reminiscence therapy is the use of sights, smells, and other sensory stimuli to evoke memories from a person’s past. The senior day care center provides the therapy through immersive environments from the 1950s, such as a department store and a barber, scenes that would be familiar to the people served by the facility.

There is currently no medicine that reverses Alzheimer’s disease and related dementias or significantly eases symptoms, so quality-of-life initiatives have become more important.

“It’s cutting edge and it’s exciting work,” Dr. Bateman said of reminiscence therapy. “One of the great pieces about the concept is that it really focuses on maintaining the dignity and the humanity of people with dementia, which can often be lost.”

Dr. Bateman’s primary research interest is studying and implementing innovative approaches to measure and treat behavioral and psychological symptoms of dementia. He focuses on the use of technology interventions to improve the health of people with dementia and their caregivers.

You can read Dr. Bateman’s interview here.

In addition to his position at Regenstrief, Dr. Batmen is an assistant professor at the Indiana University School of Medicine, an implementation scientist with the Center for Health Innovation and Implementation Science, and a co-investigator at the Indiana Alzheimer Disease Center.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org

Related News

Nov 15, 2019 • News
Indiana FSSA secretary joins Regenstrief Institute Board of Directors
Jennifer Sullivan, M.D., MPH, secretary of the Indiana Family and Social Services Administration (FSSA), has joined Regenstrief Institute’s Board of Directors. Regenstrief’s board provides strategic guidance, oversight and management for the internationally respected medical research organization in support of its mission to improve local, national and global delivery and outcomes of healthcare through research and…
Continue Reading >
Nov 15, 2019 • News
Turning data into action: Regenstrief scientists engage in national informatics discussion
Regenstrief Institute has been on the cutting edge of informatics for 50 years. Institute research scientists will present their latest research and lead discussions about the future applications of data, electronic health records and artificial intelligence at the American Medical Informatics Association 2019 Annual Symposium, November 16-20 in Washington, D.C. The annual meeting is the…
Continue Reading >